Lawyers began selecting jurors to hear a lawsuit accusing healthcare giant Johnson & Johnson of liability for patient injuries allegedly caused by the company's transvaginal mesh implants.
MASSDEVICE ON CALL — A bellwether trial against Johnson & Johnson (NYSE:JNJ) began this month with lawyers beginning to select jurors to hear a lawsuit accusing the healthcare giant of liability patient injuries allegedly caused by the company's transvaginal mesh implants.
Plaintiff Linda Gross claims that J&J subsidiary Ethicon's Prolift implant left her with severe chronic pain that prevents her from working or even sitting.
Decisions made in this trial, which is taking place in New Jersey and expected to take about 2 months, may trickle down to similar lawsuits against C.R. Bard (NYSE:BCR), Endo Pharmaceuticals Holdings (NSDQ:ENDP) and Boston Scientific (NYSE:BSX).